Non-GAAP earnings of $0.39 per class B share, for the December quarter, compared to a net loss of $0.10 per class B share for the year-earlier period. That lagged the $0.41 average estimate of analysts surveyed by Capital IQ.
Q4 sales increased 19% to $142.7 million, from $119.9 million, surpassing the analyst consensus of $136 million.
Price: 25.45, Change: +0.32, Percent Change: +1.27
|Midday ETF Update: US Stocks Fall Amid Concern on Co...|
|Sector Update: Energy|
|Altimmune's ALT-702 Meets Milestone, Shows Activity ...|
|Analyst Actions: Goldman Sachs Raises Ally Financial...|
|Analyst Actions: Piper Sandler Lifts Price Target fo...|